Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 451.4M | 183.0M | 17.4M | 25.8M | 57.0M | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -71.0M | -120.6M | -143.2M | -62.7M | -12.2M | -27.0M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -66.4M | -115.6M | -135.9M | -62.1M | -13.8M | -26.8M |
| Per Share Data | ||||||
| EPS (diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 |
| Shares Outstanding (dil.) | 42M | 38M | 29M | 25M | 21M | 6M |
Tarsus Pharmaceuticals Inc. Income Statement — FAQ
Tarsus Pharmaceuticals Inc. (TARS) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's income statement history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.